![Mark Beveridge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Beveridge
Directeur Financier/CFO chez
MOBERG PHARMA AB
Profil
Mark Beveridge currently works at Biosergen AB, as Chief Financial Officer from 2025 and Moberg Pharma AB, as Vice President-Finance from 2015.
Mr. Beveridge also formerly worked at OncoZenge AB, as Chief Financial Officer.
Mr. Beveridge received his undergraduate degree from the University of Western Sydney.
Postes actifs de Mark Beveridge
| Sociétés | Poste | Début |
|---|---|---|
| MOBERG PHARMA AB | Directeur Financier/CFO | 01/01/2015 |
| BIOSERGEN AB | Directeur Financier/CFO | 24/07/2025 |
Anciens postes connus de Mark Beveridge
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOZENGE AB | Directeur Financier/CFO | - |
Formation de Mark Beveridge
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Western Sydney
 University of Western Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moberg Pharma AB
 Moberg Pharma AB Pharmaceuticals: MajorHealth Technology Develops and commercializes medical products | Health Technology |
OncoZenge AB
 OncoZenge AB Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops products for supportive care of cancer patients | Health Technology |
Biosergen AB
 Biosergen AB BiotechnologyHealth Technology Operates as a biotechnology company that develops antifungal drugs | Health Technology |
